Anemia During Pregnancy

Julie R. Kaplan

Submitted by Anonymous (not verified) on
Full Name
Julie R. Kaplan
Profile Image URL
https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/00af0c80-50ec-11ee-9401-27bda0baf9a7.jpg
Type
Provider
Faculty
First Name
Julie
Last Name
Kaplan
NPI
1225389877
Faculty ID
15443
CMO Specialties
Clinical Terms
Employment Status
Full Time
Patient Type
Adult
Department
einstein-dept-obstetrics-gynecology-womens-health
Gender
Female
Email
jukaplan@montefiore.org
Phone
718-960-1546
Titles
Type
Academic
Department
Department of Obstetrics & Gynecology and Women's Health
Department Link
Rank
Assistant Professor
Division
General Obstetrics & Gynecology
Type
Clinical
Title
Assistant Professor, Department of Obstetrics & Gynecology and Women's Health
Type
Clinical
Title
Medical Student OBGYN Associate Clerkship Director
Locations
Is Primary
Off
Type
Clinical
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.84475 40.84623)
Address Line 1
1695 Eastchester Road
City
Bronx
State
NY
Zip
10461-237
Location Title
Montefiore Medical Park at Eastchester
Is Primary
On
Type
Clinical
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.84544 40.84518)
Address Line 1
1621 Eastchester Road
City
Bronx
State
NY
Zip
10461-2301
Location Title
Montefiore Medical Group-Comprehensive Family Care Center (CFCC)
Is Primary
Off
Type
Academic
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.8957754 40.8635153)
Address Line 1
Montefiore Medical Center
Address Line 3
2532 Grand Concourse
City
Bronx
State
NY
Zip
10458
Location Title
Montefiore Medical Center
Education and Trainings
Education Type Label
Medical Education
Education Institution
SUNY Downstate College of Medicine
Education Type Label
Residency
Education Institution
Montefiore Medical Center
CHAM Provider
Off
Professional Title
M.D.
Clinical Focus

<span style="color:#4d4d4d;font-family:Arial, Helvetica, source-code-pro, Menlo, Monaco, Consolas, 'Courier New', monospace;font-size:16px;background-color:#ffffff;">Dr. Kaplan has a special interest in prenatal care, contraception and colposcopy.</span>

Research Focus

<span style="color:#4d4d4d;font-family:Arial, Helvetica, source-code-pro, Menlo, Monaco, Consolas, 'Courier New', monospace;font-size:16px;background-color:#ffffff;">Dr. Kaplan's research interests include simulation model research and researching the long-term outcome of estrogenized endometrium in postmenopausal women.</span>

EMR ID
54522
Biography

<p>Julie Kaplan, MD is an attending physician, Assistant Professor of Obstetrics &amp; Gynecology and Women's Health and Medical Student OBGYN Associate Clerkship Director at Montefiore Einstein. She has a special interest in prenatal care, contraception and colposcopy.</p><p>After obtaining her Bachelor of Science in 2008 from Cornell University, Dr. Kaplan earned her Doctor of Medicine in 2012 at SUNY Downstate College of Medicine. She then came to Montefiore Einstein to complete an internship and residency in Obstetrics and Gynecology in 2016.</p><p>Her research interests include simulation model research and researching the long-term outcome of estrogenized endometrium in postmenopausal women. Her work has been published in the American Journal of Obstetrics and Gynecology.</p><p>Dr. Kaplan is board certified in Obstetrics and Gynecology and is a member of the American College of Obstetricians and Gynecologists.</p>

Is Open Scheduling
Off

Kira Gritsman

Submitted by Anonymous (not verified) on
Full Name
Kira Gritsman
Profile Image URL
https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/6b993220-5d55-11ef-92db-0be6da54f487.jpg
Type
Provider
Faculty
First Name
Kira
Last Name
Gritsman
NPI
1174598148
Faculty ID
14128
Clinical Terms
Employment Status
part-time
Patient Type
Adult
Department
einstein-dept-oncology
einstein-dept-medicine
einstein-dept-cell-biology
Gender
Female
Email
kira.gritsman@einsteinmed.edu
Phone
929-246-6707
Titles
Type
Academic
Department
Department of Oncology
Rank
Associate Professor
Division
Medical Oncology
Type
Academic
Department
Department of Medicine
Department Link
Rank
Associate Professor
Division
Oncology & Hematology
Type
Academic
Department
Department of Cell Biology
Department Link
Rank
Associate Professor
Type
Clinical
Title
Assistant Director of Correlative Clinical Research
Type
Administrative
Title
Co-Leader, Montefiore Einstein Comprehensive Cancer Center, Stem Cell & Cancer Biology Program
Tags
me-patientcare-cancer-clinical-aids-malignancies
me-patientcare-cancer-research-stem-cell-cancer-biology
Type
Administrative
Title
Betty and Sheldon Feinberg Senior Faculty Scholar in Cancer Research
Locations
Is Primary
On
Type
Clinical
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.88072 40.88002)
Address Line 1
111 East 210th Street
City
Bronx
State
NY
Zip
10461-2401
Location Title
Montefiore Medical Center
Is Primary
Off
Type
Academic
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.8459022 40.8504961)
Building
Chanin Building
Room
410A
Address Line 1
Albert Einstein College of Medicine
Address Line 2
Jack and Pearl Resnick Campus
Address Line 3
1300 Morris Park Avenue
City
Bronx
State
NY
Zip
10461
Location Title
Albert Einstein College of Medicine
Education and Trainings
Education Type Label
Medical Education
Education Institution
New York University School of Medicine
Education Type Label
Medical Education
Education Institution
New York University School of Medicine
Education Type Label
Medical Education
Education Institution
New York University School of Medicine
Education Type Label
Fellowship
Education Institution
Dana Farber Cancer Institute
Education Type Label
Fellowship
Education Institution
Dana-Farber Cancer Institute
Education Type Label
Residency
Education Institution
Columbia University Medical Center
Professional Interests

<p><strong>The Roles of Signaling Pathways in Adult Blood Development and Leukemia</strong></p>
<p><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">The Gritsman lab studies the signal transduction pathways that affect the early fate decisions of adult hematopoietic stem cells (HSCs) as they progress from an undifferentiated multipotent state to the generation of differentiated blood cells.&nbsp; When these early fate decisions go awry, this can lead to the formation of leukemia-initiating cells. We are interested in</span><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">&nbsp;how signaling pathways affect the self-renewal and differentiation of HSCs and malignant or pre-malignant stem cells in myeloid malignancies, such as acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and myeloproliferative neoplasms (MPN).</span></p>
<p><strong>Roles of the PI3 kinase isoforms in adult blood development</strong></p>
<p>PI3 kinase (PI3K) is a lipid kinase that is important for the regulation of metabolism, the cell cycle, apoptosis, and protein synthesis. &nbsp;In hematopoietic cells, there are four isoforms of the catalytic subunit of PI3K, each encoded by a separate gene. &nbsp;Emerging evidence suggests that these isoforms have unique functions in normal and cancer cells, but may substitute for each other in some contexts.&nbsp; We have generated a series of mouse knockout models that allow us to study the roles of each of these isoforms individually in adult hematopoiesis.&nbsp; For example, we have found that the p110alpha isoform is most important for red cell development, but is not required in normal blood stem cells. We have now also generated compound knockout mice to determine the redundant roles of the PI3K isoforms in blood development. &nbsp;We recently reported that PI3K isoforms play important redundant roles during the hematopoietic stress response, such as after chemotherapy. However, deletion of all 3 Class IA PI3K isoforms leads to a phenotype with impaired HSC differentiation, resembling myelodysplastic syndrome (MDS). We are studying how deletion of PI3K will impact normal HSC function, including self-renewal, proliferation, and differentiation along different blood lineages by affecting processes such as autophagy and epigenetic regulation in HSCs.</p>
<p><strong>Roles of the PI3 kinase isoforms in leukemia</strong></p>
<p>Acute myeloid leukemia (AML) is a genetically diverse disease, but activation of the PI3K pathway has been reported in up to 80% of cases.&nbsp; A subset of AML cell lines and AML patient samples respond to PI3K pathway inhibitors, but it is unclear how patients should be selected for potential response to these inhibitors. &nbsp;We found that RAS-mutated myeloid leukemias are particularly dependent on the p110alpha isoform of PI3K, and that pharmacologic inhibition of p110alpha can be used to treat both RAS-mutated cell lines and RAS-mutated leukemia in mice. Furthermore, we use cell lines, patient samples, and mouse models of leukemia to investigate the mechanisms of resistance to PI3K inhibition, with the goal of identifying new drug targets and designing new combination treatments for leukemia that incorporate PI3K inhibitors.</p>
<p><strong>RON Kinase in Myeloproliferative Neoplasms</strong></p>
<p>The myeloproliferative neoplasms (MPNs) are a group of diseases that are caused by kinase mutations in HSCs, which lead to uncontrolled proliferation of myeloid cells. The Philadelphia chromosome-negative MPNs are characterized by mutations in the JAK/STAT signaling pathway, and respond to JAK inhibitors, but resistance often develops. We recently discovered that the receptor Tyrosine kinase RON can physically interact with JAK2 in MPN cells, leading to potentiation of JAK/STAT signaling in resistant cells. Furthermore, we found that pharmacologic or genetic inactivation of RON can inhibit proliferation of MPN cells and re-sensitize resistant cells to JAK inhibitors.</p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman', serif;"><strong><span style="font-size: 10.5pt; font-family: Verdana, sans-serif; color: #201f1e;">Member of the Cancer Dormancy and Tumor Microenvironment Institute&nbsp;</span></strong></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman', serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: 'Times New Roman', serif;"><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">&nbsp;</span><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">The Gritsman lab&rsquo;s research interests include the contributions of signaling pathways to leukemic and pre-leukemic stem cell dormancy in minimal residual disease, which includes mechanisms of immune evasion. Furthermore, the Gritsman lab is interested in the roles of inflammatory signaling pathways and of the local microenvironment in bone marrow fibrosis, and in the evolution of myeloid neoplasms from the pre-malignant to malignant state. Our major goals are to identify opportunities for therapeutic targeting to prevent the transition from the pre-leukemic state to leukemia, or to eliminate minimal residual disease to prevent relapse.</span></p>

Research Areas
roles of signaling pathways in hematopoietic stem cell self-renewal and differentiation, leukemic stem cells, targeting signaling pathways in hematologic malignancies
CHAM Provider
Off
Professional Title
M.D.
Ph.D.
Selected Publications

<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;"><a name="_GoBack"></a><span style="font-size: 11pt; font-family: Arial, sans-serif;">Ames, K.,&nbsp;<sup>&nbsp;</sup>Kaur,<sup>&nbsp;</sup>I., Shi, Y., Tong, M., Sinclair, T., Hemmati, S., Glushakow-Smith, S.G., Tein,&nbsp;&nbsp;E., Gurska, L., Steidl, U., Dubin, R., Shan, J., Montagna, C., Pradhan, K., Verma, A., and&nbsp;<strong><u>Gritsman, K.</u></strong>, Deletion of PI3-Kinase Promotes Myelodysplasia Through Dysregulation of Autophagy in Hematopoietic Stem Cells,&nbsp;<strong><em>Science Advances</em></strong><em>&nbsp;2023.&nbsp;</em>doi:&nbsp;<a href="https://nam04.safelinks.protection.outlook.com/?url=https%3A%2F%2Fdoi.o…; target="_blank" rel="noopener"><span style="color: black; text-decoration: none;">10.1126/sciadv.ade8222</span></a><u>,&nbsp;</u>PMID:&nbsp;36812307</span></p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;"><em><span style="font-size: 11pt; font-family: Arial, sans-serif;">&nbsp;</span></em></p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;"><span style="font-size: 11pt; font-family: Arial, sans-serif;">Folgado Marco, V., Ames, K., Chuen, J.,&nbsp;<strong><u>Gritsman, K.</u></strong>&nbsp;&amp; Baker, N.,&nbsp;Haploinsufficiency of the essential gene&nbsp;<em>RpS12</em>&nbsp;causes defects in erythropoiesis and hematopoietic stem cell maintenance,&nbsp;<em>&nbsp;<strong>eLife</strong>&nbsp;</em>2023&nbsp;Jun 5;12:e69322. doi: 10.7554/eLife.69322.&nbsp;PMID:&nbsp;37272618</span></p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;"><span style="font-size: 11pt; font-family: Arial, sans-serif;">&nbsp;</span></p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;"><span style="font-size: 11pt; font-family: Arial, sans-serif;">Gurska, L.M., Okabe, R., Schurer, A., Tong, M.M., Soto, M., Choi, D., Ames, K., Glushakow-Smith, S., Montoya, A., Tein, E., Miles, L.A., Cheng, H., Hankey-Giblin, P., Levine, R.L., Goel, S., Halmos, B., and&nbsp;<strong><u>Gritsman, K.</u></strong>&nbsp;Crizotinib has Preclinical Efficacy in Philadelphia-negative Myeloproliferative Neoplasms,&nbsp;<strong><em>Clinical Cancer Research</em></strong>&nbsp;2022&nbsp;Dec 20:CCR-22-1763. doi: 10.1158/1078-0432.CCR-22-1763. PMID:&nbsp;36537918</span></p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;"><span style="font-size: 11pt; font-family: Arial, sans-serif;">&nbsp;</span></p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;"><span style="font-size: 11pt; font-family: Arial, sans-serif;">Gurska, L., Ames, K., and&nbsp;<strong><u>Gritsman, K</u></strong>, Signaling Pathways in Leukemic Stem Cells,&nbsp;</span><span style="font-size: 11pt; font-family: Arial, sans-serif; color: #333333; letter-spacing: 0.2pt; background-color: #fcfcfc;">In: Zhang H., Li S. (eds) Leukemia Stem Cells in Hematologic Malignancies.&nbsp;<strong>Advances in Experimental Medicine and Biology</strong>, vol 1143. Springer, Singapore</span><span style="font-size: 11pt; font-family: Arial, sans-serif;">, July 24, 2019, doi:&nbsp;<a href="https://doi.org/10.1007/978-981-13-7342-8_1"><span style="color: black; letter-spacing: 0.2pt; background-color: #fcfcfc; text-decoration: none;">https://doi.org/10.1007/978-981-13-7342-8_1</span></a><span style="letter-spacing: 0.2pt; background-color: #fcfcfc;">;&nbsp;</span>PMID:&nbsp;31338813, PMCID:&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7249489/&quot; target="_blank" rel="noopener"><span style="color: black; text-decoration: none;">PMC7249489</span></a></span></p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;"><span style="font-size: 11pt; font-family: Arial, sans-serif;">Hemmati, S., Sinclair, T., Tong, M., Bartholdy, B., Okabe, R.O., Ames, K., Ostrodka, L., Haque, T., Kaur, I., Mills, T. S., Agarwal, A., Pietras, E.M., Zhao, J.J., Roberts, T.M., and&nbsp;<strong><u>Gritsman, K.</u></strong>, PI3 kinase alpha and delta promote hematopoietic stem cell activation,&nbsp;<strong><em>JCI Insight&nbsp;</em></strong>2019&nbsp;doi.org/10.1172/jci.insight.125832</span></p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;"><span style="font-size: 11pt; font-family: Arial, sans-serif;">Mitchell, K., Barreyro, L., Todorova, T., Taylor, S., Antony-Debre, I., Narayanagari, S., Carvajal, L., Leite, J., Piperdi, Z., Pendurti, G., Mantzaris, I., Paietta, E., Verma, A.,&nbsp;<strong><u>Gritsman, K.,&nbsp;</u></strong>and Steidl, U. IL1RAP potentiates multiple oncogenic signaling pathways in AML,&nbsp;<strong><em>Journal of&nbsp;Experimental Medicine</em></strong><em>.&nbsp;</em>2018 May 17. doi: 10.1084/jem.20180147,&nbsp;PMID: 29773641</span></p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;"><span style="font-size: 11pt; font-family: Arial, sans-serif;">Hemmati, S., Haque, T., and&nbsp;<strong><u>Gritsman, K</u>,&nbsp;</strong>Inflammatory Signaling Pathways in Pre-leukemic and Leukemic Stem Cells,&nbsp;<strong><em>Frontiers in Oncology</em></strong><em>&nbsp;</em>2017 Nov 13;7:265. doi: 10.3389/fonc.2017.00265</span></p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;"><span style="font-size: 11pt; font-family: Arial, sans-serif;">Bhagat, T.D., Chen, S., Bartenstein, M., Barlowe, A.T., Von Ahrens, D., Choudhary, G.S., Tivnan, P., Amin, E., Marcondes, M., Sanders, M.A., Hoogenboezem, R.M., Kambhampati, S., Ramanchandra, N., Mantzaris, I., Sukrithan, V., Laurence, R., Lopez, R. Bhagat, P., Giricz, O., Sohal, D., Wickrema, A., Yeung, C.,&nbsp;<strong><u>Gritsman, K.,</u></strong>&nbsp;Aplan, P., Hochedlinger, K., Yu, Y., Pradhan, K., Zhang, J., Greally, J.M., Mukherjee, S., Pellagatti, A., Boultwood, J., Will, B., Steidl, U., Raaijmakers, M.H.G.P., Deeg, H.J., Kharas, M.G. and Verma, A. Epigenetically Aberrant Stroma in MDS Propagates Disease Via Wnt/b-Catenin Activation, 2017&nbsp;<strong><em>Cancer Research</em></strong>&nbsp;2017 Jul 6. pii: canres.0282.2017. doi: 10.1158/0008-5472</span></p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;"><span style="font-size: 11pt; font-family: Arial, sans-serif;">Yuzugullu, H., Baitsch, L., Von, T., Steiner, A., Tong, H., Ni, J., Clayton, L., Bronson, R., Roberts, T.,&nbsp;<strong><u>Gritsman, K</u></strong><u>.</u>, and Zhao, J.J. A p110b-Rac signaling loop mediates Pten-loss-induced perturbation of hematopoiesis and leukemogenesis.&nbsp;<strong><em>Nature Communication</em></strong><em>s&nbsp;</em>October 7,2015, doi:10.1038/NCOMMS9501</span></p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;"><span style="font-size: 11pt; font-family: Arial, sans-serif;">Yoda, A., Adelmant, G., Tamburini, J., Chapuy, B., Shindoh, N., Yoda, Y., Weigert, O., Kopp, N., Wu, S-C., Kim, S., Liu, H., Tivey, T., Christie, A.L.,&nbsp;<strong><u>Gritsman, K.</u></strong>,&nbsp; Gotlib, J., Deininger, M., Turley, S., Tyner, J., Marto, J., Weinstock, D.M., and Lane, A.A. Mutations in G-protein beta subunits promote transformation and kinase inhibitor resistance&nbsp;<strong><em>Nature Medicine</em></strong><em>&nbsp;</em>2015 (1):71-5.</span></p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;"><strong><u><span style="font-size: 11pt; font-family: Arial, sans-serif;">Gritsman, K</span></u></strong><strong><span style="font-size: 11pt; font-family: Arial, sans-serif;">.</span></strong><span style="font-size: 11pt; font-family: Arial, sans-serif;">, Yuzugullu, H., Von, T., Yan, H., Clayton, L., Fritsch, C., Maira, S.-M., Hollingworth, G., Choi, C., Khandan, T., Paktinat, M., Okabe, R.O., Roberts, T.M., and Zhao, J.J. &nbsp;Hematopoiesis and RAS-driven myeloid leukemia differentially require PI3K isoform p110alpha<strong>.&nbsp;<em>Journal of Clinical Investigation&nbsp;</em></strong>2014;124(4):1794&ndash;1809.&nbsp;http://www.jci.org/articles/view/69927</span></p&gt;
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;"><span style="font-size: 11pt; font-family: Arial, sans-serif;">Kharas, M.G. and&nbsp;<strong><u>Gritsman, K</u></strong>. Akt: A Double-Edged Sword for Hematopoietic Stem Cells.&nbsp;<strong><em>Cell Cycle</em>&nbsp;</strong>2010; Vol 9; Issue 7</span></p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;">&nbsp;</p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;"><span style="font-size: 11pt; font-family: Arial, sans-serif;">Kharas, M.G., Okabe, R., Ganis, J.J., Gozo,M., Khandan,T., Paktinat, M., Gilliland, D.G., and&nbsp;<strong><u>Gritsman, K</u>.</strong>&nbsp;Constitutively Active AKT Depletes Hematopoietic Stem Cells and Induces Leukemia in Mice.&nbsp;<strong><em>Blood&nbsp;</em></strong>2010; 115(7): 140615&nbsp;http://www.bloodjournal.org/content/115/7/1406</span></p&gt;
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;"><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">&nbsp;</span></p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;"><span style="font-size: 10.5pt; font-family: Verdana, sans-serif;">&nbsp;</span></p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;"><span style="font-family: 'Times New Roman', serif;">&nbsp;</span></p>
<p class="MsoNormal" style="margin: 0in; font-size: medium; font-family: Calibri, sans-serif;">&nbsp;</p>

EMR ID
73180
Is Open Scheduling
Off

Angela E. Gonzalez

Submitted by Anonymous (not verified) on
Full Name
Angela E. Gonzalez
Profile Image URL
https://assets.montefioreeinstein.org/profiles/images/default-profile-blue.svg
Type
Provider
Faculty
First Name
Angela
Last Name
Gonzalez
NPI
1700817475
Faculty ID
16017
Clinical Terms
Employment Status
Full Time
Patient Type
Adult
Department
einstein-dept-obstetrics-gynecology-womens-health
Languages
Spanish
Gender
Female
Email
anggonza@montefiore.org
Phone
718-920-9648
Titles
Type
Academic
Department
Department of Obstetrics & Gynecology and Women's Health
Department Link
Rank
Assistant Professor
Division
Minimally Invasive Gynecologic Surgery
Locations
Is Primary
Off
Type
Clinical
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.84475 40.84623)
Address Line 1
1695 Eastchester Road
City
Bronx
State
NY
Zip
10461-237
Location Title
Montefiore Medical Park at Eastchester
Is Primary
On
Type
Clinical
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.8616 40.89386)
Address Line 1
4170 Bronx Boulevard
City
Bronx
State
NY
Zip
10466-2601
Location Title
Montefiore Medical Village at Bronx River
Is Primary
Off
Type
Academic
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.861005 40.8939411)
Address Line 1
Montefiore Medical Center - Wakefield
Address Line 2
600 East 233rd Street
City
Bronx
State
NY
Zip
10466
Location Title
Montefiore Medical Center - Wakefield
Education and Trainings
Education Type Label
Medical Education
Education Institution
New York Medical College
Education Type Label
Medical Education
Education Institution
The City College of New York
Education Type Label
Residency
Education Institution
Our Lady of Mercy Medical Center, Bronx, NY
CHAM Provider
Off
Professional Title
M.D.
EMR ID
4435
Is Open Scheduling
Off

David S. Geller

Submitted by Anonymous (not verified) on
Full Name
David S. Geller
Profile Image URL
https://assets.montefioreeinstein.org/profiles/images/Geller_David_S_MD_2x.jpg
Type
Provider
Faculty
Expert
First Name
David
Last Name
Geller
NPI
1467437764
Faculty ID
10675
Clinical Terms
Employment Status
Full Time
Patient Type
Adult
Department
einstein-dept-orthopaedic-surgery
einstein-dept-pediatrics
Languages
Hebrew
Gender
Male
Email
dgeller@montefiore.org
Phone
718-920-2060
Titles
Type
Academic
Department
Department of Orthopaedic Surgery
Department Link
Rank
Professor
Type
Academic
Department
Department of Pediatrics
Department Link
Rank
Professor
Division
Pediatric Hematology-Oncology
Type
Clinical
Title
Co-Director, Orthopedic Oncology
Tags
me-patientcare-cancer-research-therapeutics
me-patientcare-cancer-clinical-aids-malignancies
me-patientcare-orthopedics-about-team-chiefs
Type
Clinical
Title
Vice-Chairman, Strategy and Innovation
Tags
me-patientcare-orthopedics-orthopediconcology
me-patientcare-orthopedics-about-team
Type
Clinical
Title
Associate Director, Musculoskeletal Oncology Lab
Type
Clinical
Title
Professor, Orthopedic Surgery and Pediatrics
Type
Administrative
Locations
Is Primary
On
Type
Clinical
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.87862 40.88032)
Address Line 1
3400 Bainbridge Avenue
City
Bronx
State
NY
Zip
10467-2404
Location Title
Montefiore Greene Medical Arts Pavilion
Is Primary
Off
Type
Clinical
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.88072 40.88002)
Address Line 1
111 East 210th Street
City
Bronx
State
NY
Zip
10467-2401
Location Title
Montefiore Medical Center
Is Primary
Off
Type
Clinical
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.99671 40.75115)
Address Line 1
435 W 31st Street, Suite 30
City
New York
State
NY
Zip
10001
Location Title
MEAC Manhattan West
Is Primary
Off
Type
Clinical
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.8820619 40.879953)
Address Line 1
111 East 210th Street
Address Line 2
Third Floor
City
Bronx
State
NY
Zip
10467
Location Title
Pediatric Oncology - Rosenthal 3
Is Primary
Off
Type
Clinical
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.7681117 41.0268898)
Address Line 1
122 Maple Avenue
City
White Plains
State
NY
Zip
10601
Location Title
White Plains Hospital Center for Advanced Medicine & Surgery
Is Primary
Off
Type
Academic
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.8785732 40.879979)
Building
MMC-MAP
Address Line 1
Montefiore Medical Center
Address Line 2
Medical Arts Pavilion
Address Line 3
3400 Bainbridge Avenue
City
Bronx
State
NY
Zip
10467
Location Title
Montefiore Medical Center
Education and Trainings
Education Type Label
Medical Education
Education Institution
Sackler School of Medicine, New York
Education Type Label
Fellowship
Education Institution
Massachusetts General Hospital
Education Type Label
Residency
Education Institution
Montefiore Medical Center
Professional Interests

<p>Dr. Geller is a full-time faculty member of the Orthopaedic Surgery Department at Montefiore Medical Center and serves as the director of the Orthopaedic Oncology Service, managing both pediatric and adult patients.&nbsp; He is the co-director of Orthopaedic Surgery at the Montefiore Medical Center Moses Campus and currently serves as the Quality Improvement Officer for the Montefiore Cancer Committee.&nbsp; His clinical focus involves primary and metastatic bone and soft tissue tumors, with a secondary interest in joint replacement in the setting of extensive bone loss.&nbsp; He has experience in navigation-guided surgery, allograft reconstruction, endoprosthetic reconstruction, and use of custom or patient-tailored reconstructive prostheses.&nbsp; His research interests include expression patterns in osteosarcoma, surgical margins in osteosarcoma, novel drug screening methods and targeted therapy for osteosarcoma using novel therapeutic modalities.&nbsp; He is extensively involved in resident and medical student education.</p>

Specialties
Expert Tags
Areas of Expertise
Musculoskeletal oncology and joint replacement (adult and pediatric)
Limb sparing surgical techniques
Innovative surgical treatments and patient-tailored implants for those who suffer from osteosarcoma and other primary bone tumors
Expert Summary

<p>Dr. Geller is an orthopaedic surgeon specializing in musculoskeletal oncology and joint replacement, and his practice encompasses adult and pediatric patients. Dr. Geller’s research interests include surface receptor expression in osteosarcoma and potential targeted therapies for the treatment of osteosarcoma. He has developed a novel murine xenograft model for osteosarcoma for the evaluation of surgical margins in osseous tumor surgery. His research additionally includes allograft bone reconstruction techniques, resonance frequency changes during joint reconstruction and pain management in the elderly orthopaedic population.</p>

CHAM Provider
Off
Professional Title
M.D.
Clinical Focus

<p>Orthopedic oncology, orthopedic surgery, bone and soft tissue sarcomas, benign bone and soft-tissue tumors, metastatic carcinoma on the bone </p>

Research Focus

<p>Osteosarcoma, with an interest in innovative treatment strategies for both local disease control and metastatic disease; evaluation of expression patterns in osteosarcoma and surgical margins using a xenograft osteosarcoma murine model; the functional role of bone morphogenetic proteins in osteosarcoma surgery; use of intraoperative navigation techniques for tumor surgery; tumorigenesis of osteosarcoma </p>

PubMed.gov URL
Selected Publications

<ul>
<li>Morris J, Dutcher J, <strong>Geller DS</strong>. Revisiting the Orhtopaedic Management of Metastatic Renal Cell Carcinoma: Rationale for a More Aggressive Approach. <em>Current Orthopaedic Practice. </em>2013 Sept/Oct; 24(5):547-551.</li>
<li>Bekarev M, Elsinger EC, Villanueva-Siles E, Borzykowski RM, <strong>Geller DS.</strong> Synovial Sarcoma of the Foot. <em>Journal of Foot and Ankle Surgery</em>. 2013 Jul-Aug; 52(4):513-7. doi: 10.1053</li>
<li>Capogna BM, Lovy A, Blum Y, Kim SJ, Flesen UR, <strong>Geller DS.</strong> Infection Rate Following Total Joint Arthroplasty in the HIV Population. <em>Journal of Arthroplasty</em>. 2013 Sep; 28(8):1254-8. doi: 10.1016</li>
<li>Lall A, Hohn E, Kim M, Gorlick R, Abraham J, <strong>Geller DS</strong>. Comparison of Surface Area Across the Allograft-Host Junction Site Using Conventional and Navigated Osteotomy Technique. <em>Sarcoma</em>. 2012; 2012:197540.&nbsp;</li>
<li>Piperdi S, Austin-Page L, <strong>Geller DS</strong>, Ahluwalia M, Gorlick S, Gill J, Sellers R, Zhang W, Li N, Ching Sohak, Gorlick R. Beta-Catenin Does Not Confer Tumorigenicity when Introduced into Partially Transformed Human Mesenchymal Stem Cells.<em> Sarcoma</em>. 2012. Epub 2012 Oct 18.</li>
<li>Crocco L, Gorlick R,<strong> Geller DS</strong>. Current Practice Management Regarding Thromboembolic Prophylaxis Within the Pediatric Sarcoma Patient Population, <em>Journal of Pediatric Hematology/Oncology</em>.2012 Sep 19. [Epub ahead of print]</li>
<li>&nbsp;Hall GL, Villanueva-Siles E, Borzykowski RM, Gruson KI, Dorfman HD, <strong>Geller</strong> <strong>DS</strong>. Aspergillus osteomyelitis of the proximal humerus: a case report. <em>Skeletal Radiology</em>. 2012 Aug; 41(8):1021-5. Epub 2012 Mar 31.</li>
<li>Sambaziotis C, Plymale M, Lovy A, O&rsquo;Halloran K, McCulloch K, <strong>Geller DS</strong>. Pseudoaneurysm of the Distal Thigh after Manipulation of a Total Knee Arthroplasty. <em>Journal of Arthroplasty</em>. 2012 Aug; 27(7); 1414.</li>
<li>Shakked RJ, <strong>Geller DS</strong>, Gorlick R, Dorfman HD. Mesenchymal chondrosarcoma: Clinicopathologic study of 20 cases. <em>The Archives of Pathology &amp; Laboratory Medicine</em>.&nbsp; 2012 Jan; 136(1):61-75.</li>
<li>Hohn E, Garfein ES, Mehta KJ, <strong>Geller DS. </strong>Quadriceps Tendon Allograft Augmentation after Wide Excision of a Soft Tissue Sarcoma. <em>Current Orthopaedic Practice</em>. 2012 Jan/Feb; 23(1):68-71.</li>
<li>Singh CK, <strong>Geller DS. </strong>The Telescopic Mating Technique for Bulk Allograft Reconstruction. <em>Orthopaedics</em>. 2012 Feb; 35(2):118-124.</li>
<li>Sambaziotis C, Lovy A, Moadel RM, Chamarthy M, Glaser J, Jaini S, Villanueva-Siles E, <strong>Geller DS</strong>. Florine-18 Fluorodeoxyglucose Positron Emission Tomography for Osteochondromas Utilizing a Triple-Time Point Protocol.&nbsp; <em>Open Journal of Medical Imaging</em>. 2011 Dec; 1(2):15-20.</li>
<li>Hassan SE, Bekarev M, Kim MY, Lin J, Piperdi S, Gorlick R, <strong>Geller DS. </strong>Cell Surface Receptor Expression Patterns in Osteosarcoma. <em>Cancer.</em> 2011 Feb 1; 118(3):740-9.</li>
<li>Plymale M, Lovy A, Villanueva-Siles E, <strong>Geller DS.</strong> Isolated intra-articular pseudorheumatoid nodule of the knee.<em> Skeletal Radiology</em>. 2011 Apr; 40(4):463-6.</li>
<li>Green MC, Dorfman HD, Villanueva-Siles E, Gorlick RG, Thornhill BA, Weber RV, <strong>Geller DS. </strong>Aggressively Recurrent Infantile Myofibroma of the Axilla and Shoulder Girdle. A Case Report. <em>Skeletal Radiology</em>.2010 Mar; 40(3):357-61.</li>
<li><strong>Geller DS</strong>, Pope JB, Thornhill BA, Dorfman, HD. Cryptococcal pyarthrosis and sarcoidosis. <em>Skeletal Radiol</em>. 2009 Jul; 38(7):721-7.</li>
<li>Sah A, <strong>Geller DS</strong>, Mankin HJ, Delaney T, Rosenberg A, Wright C, Hornicek FJ. Malignant Transformation of Synovial Chondromatosis of the Shoulder to Chondrosarcoma - A Case Report," <em>Journal of Bone and Joint Surgery. </em>2007 Jun; 89(6):1321-8.</li>
<li><strong>Geller DS</strong>, Hornicek FJ, Mankin HJ, Raskin KA. &ldquo;Soft Tissue Sarcoma Resection Volume Associated with Wound-Healing Complications,&rdquo; <em>Clinical Orthopaedics and Related Research.</em> 2007; 457:182-5.</li>
<li>Ames JA, Abraham JA, <strong>Geller DS</strong>, Goldsmith J, Gebhardt MC.&nbsp; Proximal Tibial Lesion in a Young Adult: Early Diagnosis Allowing Unique Reconstruction.&nbsp; <em>The Orthopaedic Journal at Harvard Medical School.</em> 2006 Aug: 143-7.</li>
<li>Gardner MJ, Yacoubian S, <strong>Geller DS</strong>, Pode M, Mintz D, Helfet&nbsp; DL,&nbsp; Lorich DG. &ldquo;Prediction of Soft-Tissue Injuries in Schatzker II Tibial Plateau Fractures based on Measurements of Plain Radiographs,&rdquo; <em>Journal of Trauma-Injury Infection &amp; Critical Care</em>. 2006; 60(2):319-324.</li>
<li>Steinberg EL, <strong>Geller DS</strong>, Yacoubian SV, Shasha N, Dekel S, Lorich DG. &ldquo;Intramedullary Fixation of Tibial Shaft Fractures Using an Expandable Nail,&rdquo; <em>Journal of Orthopaedic Trauma.&nbsp; </em>2006 May; 20(5):303-9.</li>
<li>Gardner, MJ, Yacoubian S, <strong>Geller DS</strong>, Suk M, Mintz D, Potter H, Helfet DL, Lorich DG. &ldquo; The Incidence of Soft Tissue Injury in Operative Tibial Plateau Fractures,&rdquo; <em>Journal of Orthopaedic Trauma</em>.&nbsp; 2005; 19:79-84.</li>
<li>Lorich DG, Yacoubian SV, <strong>Geller DS</strong>. &ldquo;Intramedullary Fixation of Humeral Shaft Fractures Using an Inflatable Nail,&rdquo; <em>Orthopaedics</em>. 2003 Oct; 26(10):1011-4.</li>
<li>Lorich DG, <strong>Geller DS</strong>, Yacoubian SV, Leo AJ, Helfet DL. &ldquo;An Innovative Mode of Intramedullary Fixation,&rdquo; <em>International Review of Modern Surgery</em>, March 2002.</li>
<li>Westrich GH, <strong>Geller DS</strong>, O&rsquo;Malley MJ, Deland JT, Helfet DL. &ldquo;Anterior Iliac Crest Bone Graft Harvesting Using the Cortico-Cancellous Reamer System,&rdquo; <em>Journal of Orthopaedic Trauma</em>. 2001 Sep-Oct; 15(7):500-6.</li>
</ul>

EMR ID
4324
Biography

<p>David S. Geller is a board-certified orthopedic oncologist who specializes in the treatment of both pediatric and adult patients with bone and soft-tissue tumors. He has been a full-time faculty member at Montefiore since 2006. He is an Associate Professor of Orthopedic Surgery and Pediatrics at our Albert Einstein College of Medicine.</p><p>Dr. Geller is known for his expertise in musculoskeletal tumor surgery, with specific experience in bone and soft-tissue sarcomas, such as osteosarcoma, Ewing's sarcoma, liposarcoma and synovial sarcoma. He has extensive experience in managing patients with metastatic carcinoma of the bone as well. He routinely offers limb-salvage surgery using a wide array of reconstructive tools.</p><p>Dr. Geller earned his medical degree from Tel Aviv University's Sackler School of Medicine and completed an orthopedic surgery residency at Montefiore. He received his fellowship training from the Harvard Combined Orthopedic Oncology Program, which included Massachusetts General Hospital, Boston Children's Hospital, and Beth Israel Deaconess Medical Center.</p><p>Dr. Geller serves as the Associate Director of the Musculoskeletal Oncology Research Laboratory at Montefiore. He leads numerous translational research efforts designed to investigate the pathophysiology and molecular mechanisms of bone and soft tissue cancers. He is interested in improved surgical techniques and novel therapeutic approaches for primary malignant bone tumors. He is actively involved in collaborative clinical trials both nationally and internationally.</p><p>Dr. Geller is an active member of the American Academy of Orthopedic Surgeons, Muskuloskeletal Tumor Society, Connective Tissue Oncology Society, Children's Oncology Group, American Orthopedic Association, and the American Association for Cancer Research.</p>

Is Open Scheduling
Off

Boguslawa D. Gela

Submitted by Anonymous (not verified) on
Full Name
Boguslawa D. Gela
Profile Image URL
https://assets.montefioreeinstein.org/profiles/images/physphoto/Gela_Boguslawa_MD-22.jpg
Type
Provider
Faculty
First Name
Boguslawa
Last Name
Gela
NPI
1164515680
Faculty ID
18275
CMO Specialties
Clinical Terms
Employment Status
Full Time
Patient Type
Adult
Department
einstein-dept-obstetrics-gynecology-womens-health
Languages
Polish
Gender
Female
Email
bgela@montefiore.org
Phone
718-409-8854
Titles
Type
Academic
Type
Academic
Department
Department of Obstetrics & Gynecology and Women's Health
Department Link
Rank
Assistant Professor
Division
General Obstetrics & Gynecology
Locations
Is Primary
On
Type
Clinical
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.84861 40.83504)
Address Line 1
2300 Westchester Avenue
City
Bronx
State
NY
Zip
10467-2836
Location Title
Montefiore Medical Group-Bronx East
Is Primary
Off
Type
Academic
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.8479384 40.8350049)
Room
B-2
Address Line 1
Montefiore Medical Center
Address Line 3
2300 Westchester Avenue
City
Bronx
State
NY
Zip
10462
Location Title
Montefiore Medical Center
Education and Trainings
Education Type Label
Medical Education
Education Institution
Akademia Medyczna W Wroclawiu
Education Type Label
Residency
Education Institution
Marie Curie - Sklodowska Hospital
Education Type Label
Residency
Education Institution
Our Lady of Mercy Medical Center, Bronx, NY
CHAM Provider
Off
Professional Title
M.D.
EMR ID
4599
Is Open Scheduling
On

Ellen Wolkin Friedman

Submitted by Anonymous (not verified) on
Full Name
Ellen Wolkin Friedman
Profile Image URL
https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/5f748650-3937-11ed-a06a-83625b154202.jpg
Type
Provider
Faculty
First Name
Ellen
Last Name
Friedman
NPI
1215026539
Faculty ID
2007
CMO Specialties
Clinical Terms
Employment Status
part-time
Patient Type
Adult
Department
einstein-dept-oncology
einstein-dept-medicine
Gender
Female
Email
elfriedm@montefiore.org
Phone
718-920-4137
Titles
Type
Academic
Department
Department of Oncology
Rank
Associate Professor
Division
Hematology
Type
Academic
Department
Department of Medicine
Department Link
Rank
Associate Professor
Division
Oncology & Hematology
Type
Clinical
Title
Acting Director, Sickle Cell Program
Tags
me-patientcare-sicklecell-about-team
Type
Administrative
Locations
Is Primary
On
Type
Clinical
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.88072 40.88002)
Address Line 1
111 East 210th Street
City
Bronx
State
NY
Zip
10461-2401
Location Title
Montefiore Medical Center
Is Primary
Off
Type
Clinical
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.84563 40.84596)
Address Line 1
1575 Blondell Avenue
City
Bronx
State
NY
Zip
10461-2601
Location Title
Montefiore Medical Park at 1575 Blondell
Is Primary
Off
Type
Clinical
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.88263 40.87994)
Address Line 1
60 East 208th Street
City
Bronx
State
NY
Zip
10467
Location Title
Montefiore at 60 East 208th Street
Is Primary
Off
Type
Academic
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.8782381 40.8799784)
Address Line 1
Montefiore Medical Center
Address Line 3
3411 Wayne Avenue
City
Bronx
State
NY
Zip
10467
Location Title
Montefiore Medical Center
Education and Trainings
Education Type Label
Medical Education
Education Institution
New York University School of Medicine
Education Type Label
Fellowship
Education Institution
New York University Medical Center
Education Type Label
Residency
Education Institution
Bellevue Hospital
Professional Interests

<p>Dr. Ellen Friedman&rsquo;s passion is the study of the blood (hematology) and ensuring that the next generation of medical practitioners are prepared to analyze and treat blood-related problems.</p>
<p>Dr. Friedman has been the Hematology Fellowship Director of Montefiore Medical Center/Albert Einstein College of Medicine since 2005. She completed a fellowship in hematology at New York University, specializing in the conditions of red cells, platelets and hematologic malignancies. She has been engaged in diagnosing and treating these conditions while simultaneously teaching medical students, medical residents and fellows in the skills and knowledge required. She trained at New York Hospital/Cornell, Bellevue, New York University and has been an attending physician in teaching programs in New York City her entire career. She has 40 years of experience in caring for patients in the Bronx both in the city hospitals and at Montefiore/Albert Einstein College of Medicine. Dr. Friedman also educates patients, lecturing nationally for National Organization of Rare Diseases and the Aplastic Anemia &amp; MDS International Foundation.</p>
<p>Dr. Friedman was elected Fellow in the American College of Physicians and is an Associate Professor of Clinical Medicine at Einstein. Her teaching has been recognized with the Best Teacher Award by the hematology-oncology fellows. Her research has focused on a variety of blood conditions including anemia, thrombocytopenia, myelodysplastic syndrome, and the safe performance of the bone marrow procedure.</p>

CHAM Provider
Off
Professional Title
M.D.
Selected Publications

<ol>
<li>Dai, T, Friedman E, Barta S. Ruxolitinib Withdrawal Syndrom Leading to Tumor Lysis. JCO 2013 June 10.</li>
<li>Lam A, Guandabolu K, Sridharan A, Jain R, Pavlos M, Chrysofakis G, Yu Y, Friedman, E, Price E, Schrier S, Verma A. Multiplicative Interaction Between Mean Corpuscular Volume and Red Cell Distribution Width in Predicting Mortality of Elderly Patients with and without Anemia. American Journal of Hematology, 2013 July 5.</li>
<li>Bhavana Konda, Swati Pathak, Inga Edwin, Priti Mishall, Sherry A. Downie, Todd R. Olson, Louis J. Reed and Ellen W. Friedman. Safe and Successful Bone Marrow Biopsy: An Anatomical and CT-Based Cadaver Study. Am. J. Hematol. 00:000-000, June 2014.</li>
</ol>

EMR ID
3276
Is Open Scheduling
Off

Daniel T. Friedman

Submitted by Anonymous (not verified) on
Full Name
Daniel T. Friedman
Profile Image URL
https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/880f93d0-7e92-11ec-9d5a-db3fba8c54fb.jpg
Type
Provider
Faculty
First Name
Daniel
Last Name
Friedman
NPI
1538180252
Faculty ID
14639
Clinical Terms
Employment Status
Full Time
Patient Type
Adult
Department
einstein-dept-oncology
einstein-dept-medicine
Gender
Male
Email
dfriedma@montefiore.org
Phone
718-405-1700
Titles
Type
Academic
Department
Department of Oncology
Rank
Assistant Professor
Tags
me-patientcare-cancer-research-therapeutics
Division
Medical Oncology
Type
Academic
Department
Department of Medicine
Department Link
Rank
Assistant Professor
Division
Oncology & Hematology
Type
Administrative
Locations
Is Primary
On
Type
Clinical
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.88263 40.87994)
Address Line 1
60 East 208th Street
City
Bronx
State
NY
Zip
10467
Location Title
Montefiore at 60 East 208th Street
Is Primary
Off
Type
Clinical
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.84563 40.84596)
Address Line 1
1575 Blondell Avenue
City
Bronx
State
NY
Zip
10461-2601
Location Title
Montefiore Medical Park at 1575 Blondell
Is Primary
Off
Type
Academic
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.8822305 40.8791652)
Address Line 1
Montefiore Medical Center
Address Line 3
60 East 208th Street
City
Bronx
State
NY
Zip
10467
Location Title
Montefiore Medical Center
Education and Trainings
Education Type Label
Medical Education
Education Institution
Cornell University Medical College
Education Type Label
Fellowship
Education Institution
Montefiore Medical Center
Education Type Label
Residency
Education Institution
Montefiore Medical Center
CHAM Provider
Off
Professional Title
M.D.
EMR ID
4745
Biography

<p>Daniel T. Friedman, MD, is Director, Community Hematology/Oncology at Montefiore Einstein and Assistant Professor, Medical Oncology at our Albert Einstein College of Medicine. He delivers community-focused care for hematology and medical oncology patients in the Bronx and Yonkers.</p><p>After earning his Doctor of Medicine from Cornell University Medical College in 1999, Dr. Friedman completed his internship and residency in internal medicine at Montefiore Einstein in 2002. He remained at Montefiore Einstein to complete an oncology fellowship in 2005.</p><p>Dr. Friedman's research has been focused on treatment outcomes and access to care. His work has been published in peer-reviewed journals and abstracts.</p><p>Dr. Friedman is board certified in Medical Oncology and Hematology.</p>

Is Open Scheduling
Off

Monica T. Foreman-Hyacinthe

Submitted by Anonymous (not verified) on
Full Name
Monica T. Foreman-Hyacinthe
Profile Image URL
https://assets.montefioreeinstein.org/profiles/images/physphoto/Foreman_Monica_MD_420x504.jpg
Type
Provider
Faculty
First Name
Monica
Last Name
Foreman-Hyacinthe
NPI
1700966264
Faculty ID
531
CMO Specialties
Clinical Terms
Employment Status
Full Time
Patient Type
Adult
Department
einstein-dept-obstetrics-gynecology-womens-health
Gender
Female
Email
mforeman@montefiore.org
Phone
914-376-9100
Titles
Type
Academic
Department
Department of Obstetrics & Gynecology and Women's Health
Department Link
Rank
Assistant Professor
Division
General Obstetrics & Gynecology
Locations
Is Primary
On
Type
Clinical
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.81878 40.99545)
Address Line 1
1075 central Park Avenue
City
Scarsdale
State
NY
Zip
10583-3242
Location Title
Montefiore Women's Center at Apple Plaza
Is Primary
Off
Type
Academic
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.824945 40.9880461)
Address Line 1
Montefiore Medical Group
Address Line 3
1075 Central Park Avenue
City
Scarsdale
State
NY
Zip
10583
Location Title
Montefiore Medical Group
Education and Trainings
Education Type Label
Medical Education
Education Institution
Icahn School of Medicine at Mt. Sinai
Education Type Label
Residency
Education Institution
Long Island Jewish Medical Center
CHAM Provider
Off
Professional Title
M.D.
Clinical Focus

General Obstetrics and Gynecology<br /><quillbot-extension-portal></quillbot-extension-portal>

EMR ID
3943
Biography

<p>Monica Foreman-Hyacinthe, MD, is Medical Site Director, Scarsdale Women's Center and Assistant Professor, Obstetrics &amp; Gynecology at Montefiore Einstein. Her clinical focus centers on general obstetrics and gynecology.</p><p>After obtaining her Bachelor of Science in psychobiology from Yale University in 1984, Dr. Foreman-Hyacinthe earned her Doctor of Medicine at Mount Sinai School of Medicine in 1988. She then completed her residency in obstetrics and gynecology at Long Island Jewish Medical Center in 1992.</p><p>Dr. Foreman-Hyacinthe is a Diplomate of The American Board of Obstetrics &amp; Gynecology. She is a Fellow of the American College of Obstetrics and Gynecology and a member of the National Medical Association. In 2022, Dr. Foreman-Hyacinthe was inducted into the Leo M. Davidoff Society for excellence in the teaching of medical students. She has served as a panelist for health topics on breast cancer, cervical cancer, fibroids, menopause and preventive healthcare.</p>

Is Open Scheduling
Off

Georgios Doulaveris

Submitted by Anonymous (not verified) on
Full Name
Georgios Doulaveris
Profile Image URL
https://assets.montefioreeinstein.org/profiles/images/physphoto/Doulaveris_Georgios_MD_420x504.jpg
Type
Provider
Faculty
First Name
Georgios
Last Name
Doulaveris
NPI
1629412952
Faculty ID
16748
Employment Status
Full Time
Patient Type
Adult
Department
einstein-dept-obstetrics-gynecology-womens-health
Gender
Male
Email
gdoulave@montefiore.org
Phone
718-904-2794
Titles
Type
Academic
Department
Department of Obstetrics & Gynecology and Women's Health
Department Link
Rank
Assistant Professor
Division
Fetal Medicine & Ultrasound
Type
Clinical
Title
Maternal Fetal Medicine Attending Physician
Type
Clinical
Title
Assistant Professor of Obstetrics, Gynecology and Women's Health
Locations
Is Primary
On
Type
Clinical
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.84475 40.84623)
Address Line 1
1695 Eastchester Road
City
Bronx
State
NY
Zip
10461-237
Location Title
Montefiore Medical Park at Eastchester
Is Primary
Off
Type
Academic
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.8460414 40.8489787)
Address Line 1
Jack D. Weiler Hospital
Address Line 3
1825 Eastchester Road
City
Bronx
State
NY
Zip
10461
Location Title
Jack D. Weiler Hospital
Education and Trainings
Education Type Label
Medical Education
Education Institution
University of Athens Medical School
Education Type Label
Fellowship
Education Institution
Montefiore Medical Center
Education Type Label
Residency
Education Institution
Montefiore Medical Center
Professional Interests

<p>Georgios Doulaveris, MD, FACOG, is Associate Program Director, Maternal-Fetal Medicine Fellowship Program and Assistant Professor, Obstetrics &amp; Gynecology and Women&rsquo;s Health at Montefiore Einstein. He specializes in detailed fetal ultrasound for the diagnosis and treatment of fetal malformations, fetal therapy and surgery, prenatal screening for aneuploidy, genetic diagnostic procedures (chorionic villus sampling and amniocentesis), diagnosis and management of fetal growth restriction, multiple gestations and placenta accreta spectrum. He also serves as Director of the Ultrasound Education Program for obstetrics &amp; gynecology residents and as Director of Research of the Fetal Medicine &amp; Ultrasound Division.</p>
<p>Dr. Doulaveris earned his Doctor of Medicine in 2010 from the National and Kapodistrian University of Athens Medical School in Athens, Greece. He then came to Weill Cornell Medicine/NewYork-Presbyterian to participate in a research fellowship in obstetrics &amp; gynecology, completing it in 2013. Following this, Dr. Doulaveris completed his residency in obstetrics &amp; gynecology in 2017 at Montefiore Einstein, being an Administrative Chief Resident during his last year of residency. He stayed at Montefiore Einstein to participate in a maternal-fetal medicine fellowship, completing it in 2020.&nbsp;</p>
<p>Building on his clinical focus, Dr. Doulaveris's research focuses on fetal therapy and surgery, prenatal screening for aneuploidy, prenatal diagnosis and management of fetal growth restriction, multiple gestations and placenta accreta spectrum. He has presented his work in oral and poster abstracts in national and international meetings as well as in peer-reviewed journals.&nbsp;</p>
<p>Dr. Doulaveris is board certified in Obstetrics &amp; Gynecology and Maternal-Fetal Medicine and a Fellow of the American Congress of Obstetricians and Gynecologists. He is a member of numerous professional organizations and societies, including the International Society of Ultrasound in Obstetrics and Gynecology, the American Institute of Ultrasound in Medicine, the Society for Maternal-Fetal Medicine and the Fetal Medicine Foundation. Dr. Doulaveris was named the World Congress 2020 Digital Ambassador by the International Society of Ultrasound in Obstetrics and Gynecology. He won the Leo M Davidoff Society Award for &ldquo;Outstanding Achievement in the Teaching of Medical Students&rdquo; from Montefiore Einstein twice, in 2016 and 2018.</p>
<h2>Education and Training</h2>
<p><strong>Medical School:</strong> National and Kapodistrian University of Athens, Greece<br /><strong>Residency:</strong>&nbsp;Albert Einstein College of Medicine/Montefiore Medical Center, Obstetrics and Gynecology<br /><strong>Fellowship:</strong> Albert Einstein College of Medicine/Montefiore Medical Center, Maternal-Fetal Medicine</p>
<h2>Board certifications</h2>
<p>American Board of Obstetrics and Gynecology (Obstetrics and Gynecology), 2019</p>
<p>American Board of Obstetrics and Gynecology (Maternal-Fetal Medicine), 2022</p>
<h2>Memberships</h2>
<p>Fellow of the American Congress of Obstetricians and Gynecologists (FACOG)</p>
<p>International Society of Utrasound in Obstetrics and Gynecology</p>
<p>Society of Maternal and Fetal Medicine</p>
<p>Fetal Medicine Foundation</p>
<p>American Institute of Ultrasound in Medicine</p>
<h2>Honors/Awards</h2>
<p><em>Leo M Davidoff Society</em> Award for &ldquo;Outstanding Achievement in the Teaching of Medical Students&rdquo; (2016, 2018)</p>

Research Areas
Obstetric Ultrasound; Gynecologic Ultrasound; Prenatal Diagnosis; Prenatal Genetics; Fetal Therapy; Placenta Accreta Spectrum; Fetal Growth Restriction
CHAM Provider
Off
Professional Title
M.D.
Clinical Focus

<p>Detailed fetal ultrasound for the diagnosis and treatment of fetal malformations, fetal therapy and surgery, prenatal screening for aneuploidy, genetic diagnostic procedures (chorionic villus sampling and amniocentesis), diagnosis and management of fetal growth restriction, multiple gestations and placenta accreta spectrum.</p>

Research Focus

Fetal therapy and surgery, prenatal screening for aneuploidy, prenatal diagnosis and management of fetal growth restriction, multiple gestations and placenta accreta spectrum.

Selected Publications

<p>Dar P, Jacobson B, MacPherson C, Egbert M, Malone F, Wapner RJ, Roman AS, Khalil A, Faro R, Madankumar R, Edwards L, Haeri S, Silver R, Vohra N, Hyett J, Clunie G, Demko Z, Martin K, Rabinowitz M, Flood K, Carlsson Y, <strong>Doulaveris G</strong>, Malone C, Hallingstrom M, Klugman S, Clifton R, Kao C, Hakonarson H, Norton ME. Cell-free DNA screening for trisomies 21, 18 and 13 in pregnancies at low and high risk for aneuploidy with genetic confirmation.&nbsp;<em>American Journal of Obstetrics and Gynecology</em>. 2022 Jan 24:S0002-9378(22)00041-2. PMID: 35085538</p>
<p>Dar P, Jacobson B, Clifton R, Egbert M, Malone F, Wapner RJ, Roman AS, Khalil A, Faro R, Madankumar R, Edwards L, Strong N, Haeri S, Silver R, Vohra N, Hyett J, Demko Z, Martin K, Rabinowitz M, Flood K, Carlsson Y, <strong>Doulaveris G</strong>, Daly S, Hallingstr&ouml;m M, MacPherson C, Kao C, Hakonarson H, Norton ME. Cell-free DNA screening for prenatal detection of 22q11.2 deletion syndrome.&nbsp;<em>American Journal of Obstetrics and Gynecology</em>. 2022 Jan 13:S0002-9378(22)00006-0. PMID: 35033576.</p>
<p><strong>Doulaveris G</strong>, Igel CM, Estrada Trejo F, Fiorentino D, Rabin-Havt S, Klugman S, Dar P. Impact of introducing cell-free DNA screening into clinical care on first trimester ultrasound. <em>Prenatal Diagnosis</em>. 2022 Jan 5. PMID: 34989002.</p>
<p><strong>Doulaveris G</strong>, Vani K, Saccone G, Chauhan SP, Berghella V. Number and quality of randomized controlled trials in obstetrics published in the top general medical and obstetrics and gynecology journals.&nbsp;<em>American Journal of Obstetrics and Gynecology</em><em> MFM</em>. 2022 Jan;4(1):100509. PMID: 34656731.</p>
<p><strong>Doulaveris G</strong>, George KE, Gressel GM, Banks E. Resident and program director confidence in resident preparedness for operative vaginal deliveries in Obstetrics and Gynecology Training Programs in the United States.&nbsp;<em>American Journal of Obstetrics and Gynecology</em><em>&nbsp;MFM</em>. 2022 Jan;4(1):100505. PMID: 34656733.</p>
<p><strong>Doulaveris G</strong>, Ryken K, Papathomas D, Estrada Trejo F, Fazzari MJ, Rotenberg O, Stone J, Roman AS, Dar P. Early prediction of placenta accreta spectrum in women with prior cesarean delivery using transvaginal ultrasound at 11 to 14 weeks.&nbsp;<em>American Journal of Obstetrics and Gynecology</em><em>&nbsp;MFM</em> 2020 Nov;2(4):100183. PMID: 33345909</p>
<p>Westcott JM, Simpson S, Chasen S, Vieira L, Stone J, <strong>Doulaveris G</strong>, Dar P, Bernstein PS, Atallah F, Dolin CD, Roman AS. Prenatally diagnosed vasa previa: association with adverse obstetrical and neonatal outcomes.&nbsp;<em>American Journal of Obstetrics and Gynecology</em><em>&nbsp;MFM</em> 2020 Nov;2(4):100206. PMID: 33345921</p>
<p>Rotenberg O, <strong>Doulaveris G</strong>, Fridman D, Renz M, Kaplan J, Xie X, Goldberg GL, Dar P. Long-term outcome of postmenopausal women with proliferative endometrium on endometrial sampling.&nbsp;<em>American Journal of Obstetrics and Gynecology</em>. 2020;S0002-9378(20)30670-0. PMID: 32640199</p>
<p><strong>Doulaveris G</strong>, Gallagher P, Romney E, Richley M, Gebb J, Rosner M, Dar P. Fetal abdominal circumference in the second trimester and prediction of small for gestational age at birth. <em>Journal of Maternal-Fetal and Neonatal Medicine.</em> 2020 Jul;33(14):2415-2421. PMID: 30482067</p>
<p>Teigen NC, Sahasrabudhe N, <strong>Doulaveris G</strong>, Xie X, Negassa A, Bernstein J, Bernstein PS. Enhanced Recovery after Surgery (ERAS) at Cesarean to Reduce Postoperative Length of Stay: A Randomized Controlled Trial. <em>American Journal of Obstetrics and Gynecology.</em> 2020 Apr;222(4):372.e1-372.e10. PMID: 31669738</p>
<p>Rotenberg O, Fridman D, <strong>Doulaveris</strong> <strong>G</strong>, Renz M, Kaplan J, Gebb J, Xie X, Goldberg GL, Dar P. Long-term outcome of postmenopausal women with non-atypical endometrial hyperplasia on endometrial sampling. <em>Ultrasound in Obstetrics and Gynecology.</em> 2020 Apr;55(4):546-551. PMID: 31389091</p>
<p><strong>Doulaveris G</strong>, Orfanelli T, Benn K, Zervoudakis I, Skupski D, Witkin SS. A polymorphism in an autophagy-related gene, ATG16L1, influences time to delivery in women with an unfavorable cervix who require labor induction. <em>Journal of Perinatal Medicine.</em> 2013;41(4):411-4. PMID: 23633462</p>
<p>Ramer I, Kruczek A, <strong>Doulaveris G</strong>, Orfanelli T, Shulman B, Witkin SS, Spandorfer SD. Reduced Circulating Concentration of Brain-derived Neurotrophic Factor is Associated with Peri- and Post-implantation Failure following In Vitro Fertilization-Embryo Transfer. <em>American Journal of Reproductive Immunology.</em> 2016;75(1):36-41. PMID: 26547395</p>
<p>Rotenberg O, Renz M, Reimers L, <strong>Doulaveris G</strong>, Gebb J, Goldberg GL, Dar P. Simultaneous endometrial aspiration and sonohysterography for the evaluation of endometrial pathology in women aged 50 years and older. <em>Obstetrics &amp; Gynecology.</em> 2015;125(2):414-23. PMID: 25568988</p>
<p>Lekovich J, Witkin SS, <strong>Doulaveris G</strong>, Orfanelli T, Shulman B, Pereira N, Rosenwaks Z, Spandorfer SD. Elevated serum interleukin-1b levels and interleukin-1b-to-interleukin-1 receptor antagonist ratio 1 week after embryo transfer are associated with ectopic pregnancy. <em>Fertility Sterility.</em> 2015;104(5):1190-4. PMID: 26279136</p>
<p>Orfanelli T, <strong>Doulaveris G</strong>, Holcomb K, Jeong JM, Sisti G, Kanninen TT, Caputo TA, Gupta D, Witkin SS. Inhibition of autophagy in peripheral blood mononuclear cells by vaginal fluid from women with a malignant adnexal mass. <em>International Journal of Cancer.</em> 2015;137(12):2879-84. PMID: 26132572</p>
<p>Jayaram A, Esbrand F, <strong>Doulaveris G</strong>, Orfanelli T, Sobel R, Ledger WJ, Witkin SS. Decreased concentration of protease inhibitors: possible contributors to allodynia and hyperalgesia in women with vestibulodynia. <em>American Journal of Obstetrics and Gynecology.</em> 2015;212(2):184.e1-4. PMID: 25068559</p>

EMR ID
56315
Biography

<p>Georgios Doulaveris, MD, FACOG, is Associate Program Director, Maternal-Fetal Medicine Fellowship Program and Assistant Professor, Obstetrics &amp; Gynecology and Women&rsquo;s Health at Montefiore Einstein. He specializes in detailed fetal ultrasound for the diagnosis and treatment of fetal malformations, fetal therapy and surgery, prenatal screening for aneuploidy, genetic diagnostic procedures (chorionic villus sampling and amniocentesis), diagnosis and management of fetal growth restriction, multiple gestations and placenta accreta spectrum. He also serves as Director of the Ultrasound Education Program for obstetrics &amp; gynecology residents and as Director of Research of the Fetal Medicine &amp; Ultrasound Division.</p><p>Dr. Doulaveris earned his Doctor of Medicine in 2010 from the National and Kapodistrian University of Athens Medical School in Athens, Greece. He then came to Weill Cornell Medicine/NewYork-Presbyterian to participate in a research fellowship in obstetrics &amp; gynecology, completing it in 2013. Following this, Dr. Doulaveris completed his residency in obstetrics &amp; gynecology in 2017 at Montefiore Einstein, being an Administrative Chief Resident during his last year of residency. He stayed at Montefiore Einstein to participate in a maternal-fetal medicine fellowship, completing it in 2020.</p><p>Building on his clinical focus, Dr. Doulaveris's research focuses on fetal therapy and surgery, prenatal screening for aneuploidy, prenatal diagnosis and management of fetal growth restriction, multiple gestations and placenta accreta spectrum. He has presented his work in oral and poster abstracts in national and international meetings as well as in peer-reviewed journals.</p><p>Dr. Doulaveris is board certified in Obstetrics &amp; Gynecology and Maternal-Fetal Medicine and a Fellow of the American Congress of Obstetricians and Gynecologists. He is a member of numerous professional organizations and societies, including the International Society of Ultrasound in Obstetrics and Gynecology, the American Institute of Ultrasound in Medicine, the Society for Maternal-Fetal Medicine and the Fetal Medicine Foundation. Dr. Doulaveris was named the World Congress 2020 Digital Ambassador by the International Society of Ultrasound in Obstetrics and Gynecology. He won the Leo M Davidoff Society Award for &ldquo;Outstanding Achievement in the Teaching of Medical Students&rdquo; from Montefiore Einstein twice, in 2016 and 2018.</p>

Is Open Scheduling
Off

Pe'er Dar

Submitted by Anonymous (not verified) on
Full Name
Pe'er Dar
Profile Image URL
https://assets.montefioreeinstein.org/profiles/images/physphoto/Peer_Dar_MD_420x504.jpg
Type
Provider
Faculty
Expert
First Name
Pe'er
Last Name
Dar
NPI
1801976386
Faculty ID
10177
Clinical Terms
Employment Status
Full Time
Patient Type
Pediatric
Department
einstein-dept-obstetrics-gynecology-womens-health
Gender
Male
Email
pdar@montefiore.org
Phone
718-405-8218
Titles
Type
Academic
Department
Department of Obstetrics & Gynecology and Women's Health
Department Link
Rank
Professor
Division
Fetal Medicine & Ultrasound
Type
Administrative
Title
Director, Ultrasound & Fetal Medicine, Department of Obstetrics & Gynecology and Women's Health
Locations
Is Primary
On
Type
Clinical
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.84475 40.84623)
Address Line 1
1695 Eastchester Road
City
Bronx
State
NY
Zip
10461-237
Location Title
Montefiore Medical Park at Eastchester
Is Primary
Off
Type
Academic
Location (Address, State, City, Zip)
Not used, will be deleted
Coordinates
POINT (-73.845166 40.8462736)
Room
L4
Address Line 1
Montefiore Medical Park
Address Line 3
1695 Eastchester Road
City
Bronx
State
NY
Zip
10461
Location Title
Montefiore Medical Park
Education and Trainings
Education Type Label
Medical Education
Education Institution
Sackler School of Medicine, New York
Education Type Label
Fellowship
Education Institution
Montefiore Medical Center
Education Type Label
Residency
Education Institution
Assaf Harofeh Hospital
Education Type Label
Residency
Education Institution
Albert Einstein College of Medicine
Professional Interests

<p>Dr Dar is the director of the division of fetal medicine at Montefiore Medical Center.&nbsp;He&nbsp;was trained in obstetrics and&nbsp;gynecology and&nbsp;high risk pregnancy in Israel and&nbsp;completed&nbsp;further training in obstetrics and gynecology and clinical genetics in the USA. In addition, Dr Dar&nbsp;completed training in fetal surgery in Europe.</p>
<p>Dr Dar is specialized in:</p>
<p>1.&nbsp;Prenatal diagnosis: Prenetal&nbsp;screening including First trimester screening for Down syndrome; Detailed fetal anatomy scans in early and&nbsp;late second trimester (including early transvaginal scans); Fetal echocardiography;&nbsp;Neurosonography; CVS; amniocentesis; cordocentesis and placental biopsies.</p>
<p>2. In Utero procedures and surgery: Fetoscopic laser ablation for twin to twin transfusion syndrome (TTTS), RFA for TRAP syndrome,&nbsp;EXIT procedures, Selective fetal reductions, fetal blood transfusions,&nbsp;in-utero placement of vesico-amniotic shunts and thoracoamniotic shunts;&nbsp;</p>

Areas of Expertise
Fetal Medicine
Ultrasound
Prenatal screening
High-risk pregnancy
Expert Summary

<p>Dr. Dar was trained in obstetrics and gynecology and high risk pregnancy in Israel and completed further training in obstetrics and gynecology and clinical genetics in the U.S. In addition, Dr. Dar completed training in fetal surgery in Europe. Dr. Dar specializes in prenatal screening, including first trimester screening for Down syndrome; Detailed fetal anatomy scans in early and late second trimester (including early transvaginal scans); Fetal echocardiography; Neurosonography; CVS; amniocentesis; cordocentesis and placental biopsies. He also performs in utero procedures and surgery, which includes Fetoscopic laser ablation for twin to twin transfusion syndrome (TTTS), RFA for TRAP syndrome, EXIT procedures, Selective fetal reductions, fetal blood transfusions, in-utero placement of vesico-amniotic shunts and thoracoamniotic shunts.</p>

CHAM Provider
On
Professional Title
M.D.
Clinical Focus

<table><tbody><tr><td><span style="font-family:'Arial',sans-serif;color:#373A3C;">Prenatal diagnosis by ultrasound of placental and fetal abnormalities</span><br /><span style="font-family:'Arial',sans-serif;color:#373A3C;">Prenatal genetic diagnosis of fetal disorders</span><br /><span style="font-family:'Arial',sans-serif;color:#373A3C;">Management of pregnancies complicated by all fetal abnormalities</span><br /><span style="font-family:'Arial',sans-serif;color:#373A3C;">Management of complicated twin and other multiple pregnancies </span><br /><span style="font-family:'Arial',sans-serif;color:#373A3C;">Fetal therapy</span><br /><span style="font-family:'Arial',sans-serif;color:#373A3C;">Fetal surgery including fetsocopic surgery for TTTS </span> </td></tr></tbody></table>

Research Focus

<p style="line-height:150%;">Fetal medicine and surgery</p><p style="line-height:150%;">Non-invasive prenatal screening (cell free DNA)</p><p style="line-height:150%;">Scar pregnancies and placenta accreta spectrum (PAS)</p><p style="line-height:150%;">Ultrasound in obstetrics and gynecology</p>

Selected Publications

<p style="text-align: left; padding-left: 30px;">1. Mazor M, <strong>Zitzer P</strong>, Chaim W, Maymon E, Kuperman O<em>. C-reactive protein as a marker of infection in women with preterm delivery.</em> Harefuah.[Hebrew] 1993:1;124(3); 132-137.</p>
<p style="text-align: left; padding-left: 30px;">2. Maymon R, <strong>Zitzer P</strong>, Manor Y, Bukovsky I, Moroz C<em>. Placental isoferitin patterns&nbsp; during normal first trimester and tubal gestations</em>. Hum Reprod. 1995:10(9); 2445-2447.</p>
<p style="text-align: left; padding-left: 30px;">3. Langer R, Pansky M,<strong> Zitzer P</strong>, Bukovsky I, Golan A<em>. National Urogynecologic Survey</em>. Isr J Obstet Gynecol. 1996 :7;145-149.</p>
<p style="text-align: left; padding-left: 30px;">4. <strong>Zitzer P</strong>, Panski M, Maymon R, Langer R, Bukovski I, Golan A. <em>Pelvic splenosis as a cause of low abdominal pain- Laparoscopic management</em>. Human Reprod. 1998 :13(6);101-103.</p>
<p style="text-align: left; padding-left: 30px;">5. Arieli S, <strong>Zitzer P</strong>, Bukovsky I, Maymon R<em>. Metabolic alkalosis at term pregnancy causing fetal deterioration and distress. </em>Isr J Obstet Gynecol 1999: 10; 61-63</p>
<p style="text-align: left; padding-left: 30px;">6. <strong>Dar P</strong>, Weiner I, Sofrin O, Sachs GS, Bukovsky I, Arieli S. <em>Clinical and sonographic fetal weight estimations in active labor with ruptured membranes</em>. J Reprod Med. 2000:45(5); 390-394.</p>
<p style="text-align: left; padding-left: 30px;">7. &nbsp;<strong>Dar P,</strong> Gross SJ. <em>Craniofacial and neck anomalies</em>. Clin Perinatol 2000;27(4);813-837</p>
<p style="text-align: left; padding-left: 30px;">8. <strong>Dar P</strong>, Gross SJ. <em>Macrosomia-a genetic perspective</em>. Clin Obstet Gynecol. 2000:43(2); 298-308.</p>
<p style="text-align: left; padding-left: 30px;">9. <strong>Dar P</strong>, Sachs GS, Strassburger D, Bukovsky I, Arieli S. <em>Ovarian function before and after salpingectomy in artificial reproductive technology patients</em>. Hum Reprod. 2000:15(1);142-144</p>
<p style="text-align: left; padding-left: 30px;">10. <strong>Dar P,</strong> Sachs SG, Carter SM, Ferreira JC, Nitowsky HM, Gross SJ. <em>Prenatal diagnosis of Bardet-Biedl syndrome by targeted second trimester sonography. </em>Ultrasound Obstet Gynecol 2001 Apr;17(4):354-6</p>
<p style="text-align: left; padding-left: 30px;">11. Sherer DM, <strong>Dar P</strong>. <em>Prenatal ultrasonographic diagnosis of congenital umbilical hernia and associated patent omphalomesenteric duct</em>. Gynecol Obstet Invest. 2001:51(1); 66-68</p>
<p style="text-align: left; padding-left: 30px;">12<em>.</em><strong> Dar P</strong>, Strassburger D, Shaish A, Levkovitz H, Halperin R, Harats R<em>.</em><em> Reduced reproduction with increased abortion rate in transgenic mice that overexpress 15-Lipoxygenase.</em>Gynecol Obstet Invest. 2001;52(1):18-21.</p>
<p style="text-align: left; padding-left: 30px;">13. <strong>Dar P</strong>, Javed AA, Ben-Yishay M, Ferreira JC, Paterson AD, Gross SJ, Chitayat D, Morrow BE, Nitowsky HM. <em>Potential Mapping of Corneal Dermoids to Xq24-qter</em>. J Med Genetics. 2001;38(10):719-23</p>
<p style="text-align: left; padding-left: 30px;">14. Halperin R, Zehavi S, <strong>Dar P</strong>, Habler L, Hadas E, Bukovsky I, Schneider D<em>. Clinical and molecular comparison between borderline serous ovarian tumors and advanced serous papillary ovarian carcinomas</em>. Eur J Gynaecol Oncol. 2001;22(4):292-6.</p>
<p style="text-align: left; padding-left: 30px;">15. Gross SJ, Ferreira JC, Morrow BE, <strong>Dar P,</strong> Funke B, Khabele D, Merkatz I. Gene expression profile of trisomy-21 placentas &ndash; a potential approach for designing non-invasive techniques of prenatal diagnosis. Am J Obstet Gynecol. 2002. 187(2):457-62</p>
<p style="text-align: left; padding-left: 30px;">16. Vaknin Z, Halperin R, Schneider D, Teitler J, <strong>Dar P</strong>, Herman A, Herman A, Berkovitch M. <em>Hyperemesis gravidarum and nonspecific abnormal EEG findings: a preliminary </em>report. J Reprod Med. 2006 ;51(8):623-7.</p>
<p style="text-align: left; padding-left: 30px;">17. Canick JA, Lambert-Messerlian GM, Palomaki GE, Neveux LM, Malone FD, Ball RH, Nyberg DA, Comstock CH, Bukowski R, Saade GR, Berkowitz RL, <strong>Dar P</strong>, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, D'Alton ME. First and Second Trimester Evaluation of Risk (FASTER) Trial Research Consortium. <em>Comparison of Serum Markers in First-Trimester Down Syndrome Screening.</em> Obstet Gynecol. 2006 ;108(5):1192-1199.</p>
<p style="text-align: left; padding-left: 30px;">18. Dugoff L, Cuckle HS, Hobbins JC,&nbsp; Malone FD, Belfort MA, Nyberg DA,&nbsp; Comstock CH,&nbsp; Saade GR, Eddelman KA, <strong>Dar P,</strong>&nbsp; Craigo AD,&nbsp; Timor Tritsch IE, Carr SR, Wolfe HM, D&rsquo;alton ME <sup>&nbsp;</sup>for the FASTER Trial Research Consortium. <em>Prediction of patient-specific risk for fetal loss using maternal characteristics and first and second trimester maternal serum Down syndrome markers.</em>&nbsp; Am J Obstet Gynecol. 2008 Sep;199(3):290.e1-6.</p>
<p style="text-align: left; padding-left: 30px;">19. <strong>Dar P,</strong> Karmin I, Einstein MH. <em>Arteriovenous Malformations of the Uterus: Long-Term Follow-Up.</em> Gynecol Obstet Invest. 2008 11;66(3):157-161</p>
<p style="text-align: left; padding-left: 30px;">20. Rotenberg, O., Shahabi, S., Dar, P. <em>Testosterone secreting mature ovarian teratoma causing virilization in an adolescent - Sonographic and color Doppler characteristics.</em> J Ultrasound Med. 2009 ;28(1):85-8</p>
<p style="text-align: left; padding-left: 30px;">21. D&rsquo;Alton ME, Cleary-Goldman J,&nbsp; Lambert-Messerlian G, Ball RH,&nbsp; Nyberg DA,&nbsp; Comstock CH,&nbsp; Bukowski R, Berkowitz RL,&nbsp; <strong>Dar P</strong>, Dugoff L, Craigo SD, Timor IE, Carr SR, Wolfe HM, Dukes K,&nbsp; Canick JA, Malone FD. <em>Maintaining quality assurance for nuchal translucency sonography: Lessons from the FASTER trial</em>.&nbsp; Ultrasound Obstet Gynecol. 2009 27;33(2):142-146</p>
<p style="text-align: left; padding-left: 30px;">22. Gebb J, <strong>Dar P</strong>. <em>Should the First Trimester Aneuploidy Screen be Maternal Age Adjusted? Screening by Absolute Risk vs. Risk Adjusted to Maternal Age.</em> Prenatal Diagnosis. 2009; 29 (3) 245-247</p>
<p style="text-align: left; padding-left: 30px;">23. Terry S., Banks E., Harris K., Duvivier R., <strong>Dar P</strong>. <em>Comparison of 3-dimensional to 2-dimensional Saline Infusion Sonohysterograms for the Evaluation of Intrauterine Abnormalities.</em> J Clinic Ultrasound. 2009 ;37(5):258-62.</p>
<p style="text-align: left; padding-left: 30px;">24. <strong>Dar P</strong>, Rosenthal J,Factor S, DubiossoR, Murthy AS <em>First trimester diagnosis of fetal epignathus with two and three-dimensional ultrasonography</em><strong>. </strong>J Ultrasound Med. 2009 Dec;28(12):1743-6</p>
<p style="text-align: left; padding-left: 30px;">25.&nbsp; Ram K, Goffman D, Ilagan J, <strong>Dar P</strong>. <em>First trimester diagnosis of familial split-hand split-foot malformation (SHFM)</em>. J Ultrasound Med. 2009 ;28(10):1397-400.</p>
<p style="text-align: left; padding-left: 30px;">26. <strong>Dar P</strong>, Gebb J, Reimers L, Bernstein PB, Chazotte C, Merkatz IR. <em>First trimester 3-dimensional power Doppler of the utero-placental circulation space: A potential screening method for preeclampsia. </em>AJOG. 2010 ;203(3):238.e1-7.</p>
<p style="text-align: left; padding-left: 30px;">27. <strong>Dar P</strong>, Gebb J. <em>Reply: First-trimester 3-dimensional power Doppler for the screening of preeclampsia: the analysis of a greater proportion of the uteroplacental unit might improve the accuracy of the method </em>.AJOG. 2011 Feb;204(2):e5-6.</p>
<p style="text-align: left; padding-left: 30px;">28. Gebb J, Demasio K, <strong>Dar P</strong>. <em>Prenatal sonographic diagnosis of a familial Saethre-Chotzen Syndrome. </em>J Ultrasound Med. 2011;30(3):420-2</p>
<p style="text-align: left; padding-left: 30px;">29. Gebb J, <strong>Dar P</strong>. <em>Color Doppler ultrasound of spiral artery blood flow in the prediction of preeclampsia and intrauterine growth restriction</em>. Best Prac Res Clin Obstet Gynecol. 2011. In press</p>

EMR ID
4197
Biography

<p>Pe&rsquo;er Dar, MD, is Director of Fetal Medicine and OBGYN Ultrasound at Montefiore and Professor of Obstetrics and Gynecology and Women&rsquo;s Health at our Albert Einstein College of Medicine. Dr. Dar&rsquo;s clinical focus is on the care of women who carry babies with disorders and medical conditions that may affect their lives and he leads the Fetal Medicine and Surgery Team at Montefiore. He particularly specializes in diagnosis and management of medical and structural abnormalities in the fetus and in complicated twin and triplet pregnancies. His expertise include performing detailed ultrasound examination of the fetus including fetal echocardiography (scanning of the fetal heart) and fetal neurosonography (scanning of the fetal brain) as well as performing in-utero fetal surgeries such as fetoscopic laser surgery for monochorionic twins with twin to twin transfusion syndrome, in-utero blood transfusion for fetuses with anemia and in-utero drainage and shunt procedures. Dr. Dar is also experienced in performing amniocentesis, chorionic villous sampling (CVS) and multifetal selective reduction for multiple pregnancies.&nbsp;&nbsp;&nbsp;&nbsp;</p><p>Dr. Dar completed his Doctor of Medicine from Tel-Aviv University in Tel-Aviv, Israel in 1986. He started his postgraduate education at Assaf Harofe Medical Center, Tel-Aviv University, with a residency in obstetrics and gynecology and a specialty in high-risk pregnancies from 1992 through 1998. He then came to Montefiore-Einstein, completing a two-year fellowship in medical and reproductive genetics. After spending two years as an attending-specialist in the field of prenatal diagnosis he completed in 2005 three-year residency in obstetrics and gynecology at Montefiore-Einstein. In 2007, he completed additional training in fetal surgery in world-known fetal surgery centers in France and Belgium. &nbsp;</p><p>Dr. Dar is very active in research and he is currently the principal investigator in many studies including international multicenter studies. His research focus is in fetal medicine and surgery, non-invasive prenatal screening and placenta accreta spectrum. He has shared his work in many peer-reviewed journals, textbook chapters, abstracts and invited presentations. He is also a reviewer for national and international journals including the <em>American Journal of Obstetrics and Gynecology, Plos one and Prenatal Diagnosis. </em></p><p>Dr. Dar is board certified in both Obstetrics and Gynecology and Clinical Genetics and is a member of several professional societies including the Society of Maternal and Fetal Medicine, International Fetal Medicine and Surgery Society and the International Society of Ultrasound in Obstetrics and Gynecology. He has been regularly listed among Castle Connolly Top Doctors for obstetrics and gynecology in the New York Metro area.</p>

Is Open Scheduling
Off
Subscribe to Anemia During Pregnancy